Cynthia J. Moreland - Oct 20, 2021 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
Director
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Stock symbol
TGAN
Transactions as of
Oct 20, 2021
Transactions value $
$0
Form type
4
Date filed
10/22/2021, 04:04 PM
Next filing
Oct 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Award $0 +30K $0.00 30K Oct 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TGAN Stock Option (right to buy) Award $0 +50K $0.00 50K Oct 20, 2021 Common Stock 50K $4.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). One-fourth (1/4) of the RSUs will vest on October 20, 2022, and the remaining shares will vest in equal quarterly installments over the following three years, subject to the Reporting Person's continued service as of each such vesting date.
F2 One-fourth (1/4) of the shares subject to the option will vest on October 20, 2022, and the remaining shares will vest in equal quarterly installments over the following three years, subject to the Reporting Person's continued service as of each such vesting date.